This Research Topic is the second volume in the series: Cuproptosis and Tumors. The previous volume can be viewed here: Volume I
Cuproptosis is a novel mode of cell death distinct from other forms of programmed cell death. The role and mechanism of cuproptosis in both tumor and non-tumor diseases remain unclear and require further exploration. Inducing programmed death of abnormal cells is one of the potential methods for future disease treatment and prevention. By triggering cuproptosis in abnormal cells, we can inhibit the progression of diseases and ultimately achieve the goal of curing them.
Previously, we organized a special issue titled "Cuproptosis and Tumors" and received enthusiastic responses. We believe that such discussions contribute to a deeper understanding of the mechanisms and significance of cuproptosis in tumor and non-tumor diseases in the academic community, thus improving patient care.
Therefore, we organize this new special issue for academic discussions. The theme of this special issue is "Cuproptosis in Tumor: From Basic Research to Clinical Translation." We will focus on the mechanisms of cuproptosis in tumor and non-tumor diseases and pay attention to new therapeutic strategies and methods based on cuproptosis.
We welcome all submissions related to basic research and clinical translation studies on cuproptosis, including experimental articles and review articles.
Keywords:
Cuproptosis, Cell death, Drug delivery system, Theranostics, Tumor and non-tumor diseases
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
This Research Topic is the second volume in the series: Cuproptosis and Tumors. The previous volume can be viewed here:
Volume I Cuproptosis is a novel mode of cell death distinct from other forms of programmed cell death. The role and mechanism of cuproptosis in both tumor and non-tumor diseases remain unclear and require further exploration. Inducing programmed death of abnormal cells is one of the potential methods for future disease treatment and prevention. By triggering cuproptosis in abnormal cells, we can inhibit the progression of diseases and ultimately achieve the goal of curing them.
Previously, we organized a special issue titled "Cuproptosis and Tumors" and received enthusiastic responses. We believe that such discussions contribute to a deeper understanding of the mechanisms and significance of cuproptosis in tumor and non-tumor diseases in the academic community, thus improving patient care.
Therefore, we organize this new special issue for academic discussions. The theme of this special issue is "Cuproptosis in Tumor: From Basic Research to Clinical Translation." We will focus on the mechanisms of cuproptosis in tumor and non-tumor diseases and pay attention to new therapeutic strategies and methods based on cuproptosis.
We welcome all submissions related to basic research and clinical translation studies on cuproptosis, including experimental articles and review articles.
Keywords:
Cuproptosis, Cell death, Drug delivery system, Theranostics, Tumor and non-tumor diseases
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.